Home/SEC 13D/G/CRLSEC 13D/GCRL - Charles River Laboratories Inte - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified$CRL$260.12▲ 28.50% YTDHealthcareAug 6, 2026 · ThinkSabio BlogSEC Filing Update: #CRL Charles River Laboratories Inte : $260.12 Sector: Healthcare | YTD: 🔼+ 28.50% The SEC disclosed Today (06-AUG-2026) that FMR LLC has INCREASED #CRL Shares by 22.67% 🟢 * Previous Holdings: 3.46M Shares * Current Holdings: 4.24M Shares * Increase+783.51K * Increased(%)+22.67% * Ownership: 8.8% * Estimated Investment Value: $186.38M https://www.thinksabio.com/reports/isr/CRL Institutional ownership in #CRL has been steadily rising over the past 3 quarters in Shares: Q3 2025: 50.43M Q4 2025: 52.87M Q1 2026: 57.11M The quarterly average prices of #CRL: Q3 2025: $158.77 Q4 2025: $181.05 Q1 2026: $185.45 Share this post🔗Copy LinkMore filings for $CRLCRL - Charles River Laboratories Inte - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 13, 2026💬 Comments Loading comments…Leave a commentPost Comment← All PostsMore SEC 13D/G